BOLD

Boundless Bio, Inc. BOLD

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode BOLD QTTB NXTC PSTV INTS ITRM ANTX PLUR RLYB SONN
6M 21.15 % 99.35 % 103.90 % 178.87 % 48.01 % -60.56 % 2.73 % -12.63 % 148.32 % 5.88 %
YTD -53.85 % -10.43 % 16.63 % -54.15 % -76.57 % -78.66 % -18.71 % -20.09 % -19.90 % -21.25 %
1Y -50.00 % -7.49 % 0.88 % -45.35 % -79.50 % -77.69 % -11.02 % -21.36 % -22.03 % -20.75 %
3Y 12 599 900.00 % -86.79 % -25.71 % -88.37 % -93.12 % -60.87 % -88.47 % -55.41 % -85.80 % -99.25 %
5Y 12 599 900.00 % -98.66 % -90.79 % -98.31 % -93.12 % -97.34 % -92.66 % -93.00 % -94.60 % -99.99 %
10Y 12 599 900.00 % -99.08 % -95.18 % -100.00 % -93.12 % -99.80 % -92.66 % -96.21 % -94.60 % -100.00 %
From the beginning 12 599 900.00 % -99.08 % -95.18 % -100.00 % -93.12 % -99.80 % -92.66 % -99.98 % -94.60 % -100.00 %

Dividend

AN2 Therapeutics, Inc.